Lessons from precision medicine and early phase trials: Dr. Kurzrock (2022)

In this conversation with PALTOWN Scientific Director Manju George, Dr. Kurzrock of UCSD discusses how precision medicine is impacting phase I clinical trials for colorectal cancer. She also looks at common misperceptions of phase I trials.